The interaction between the viral spike protein and ACE2, which initiates the virus’s entry into host cells, may contribute to the cardiovascular manifestations of COVID-19, in addition to the impacts of respiratory infection and inflammation (Nishiga et al., 2020). The gene discussed is ACE2; the disease is COVID-19.